Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3
Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3
复制标题
DOI:
10.1126/science.285.5429.886
复制
发表时间:
1999-08-06
期刊:
影响因子:
56.9
通讯作者:
Allis, CD
中科院分区:
文献类型:
--
作者:
Sassone-Corsi, P;Mizzen, CA;Allis, CD
During the immediate-early response of mammalian cells to mitogens, histone H3 is rapidly and transiently phosphorylated by one or more unidentified kinases. Rsk-2, a member of the pp90(rsk) family of kinases implicated in growth control, was required for epidermal growth factor (EGF)-stimulated phosphorylation of H3. RSK-2 mutations in humans are Linked to Coffin-Lowry syndrome (CLS). Fibroblasts derived from a CLS patient failed to exhibit EGF-stimulated phosphorylation of H3, although H3 was phosphorylated during mitosis. Introduction of the wild-type RSK-2 gene restored EGF-stimulated phosphorylation of H3 in CLS cells. In addition, disruption of the RSK-2 gene by homologous recombination in murine embryonic stem cells abolished EGF-stimulated phosphorylation of H3. H3 appears to be a direct or indirect target of Rsk-2, suggesting that chromatin remodeling might contribute to mitogen-activated protein kinase-regulated gene expression.